Transglutaminase 2 antibody | knockout validation | Abcam ab2386

This is a knockout-validated antibody summary, based on the publication "Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Transglutaminase 2 antibody | knockout validation | Abcam ab2386 figure 1
Figure 1. Representative images of immunocytochemistry staining of TG2 in the TG2 KO, SMAD3 KO and WT IPF fibroblasts. TG2 (green), Hoechst (blue). From [1].
Antibody information

Mouse monoclonal IgG1

Company: Abcam

Antibody: Transglutaminase 2

Catalog number: ab2386

Summary: Mouse monoclonal antibody against full length native protein (purified) corresponding to Transglutaminase 2. Reacts with mouse, rabbit, guinea pig, cat, dog, and human. Suitable for western blot, immunocytochemistry/immunofluorescence, immunohistochemistry (paraffin) and flow cytometry.

Validation Method

Immunocytochemistry

Sample

WT and TG2 KO idiopathic pulmonary fibrosis (IPF) fibroblasts.

Clone note

The same clone (CUB 7402) is sold as LifeSpan Biosciences LS-C87955, LS-C87956, LS-B8560; Abcam ab2386; Invitrogen MA5-12736, MA5-12739.

References
  1. Fell S, Wang Z, Blanchard A, Nanthakumar C, Griffin M. Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors. Amino Acids. 2021;53:205-217 pubmed publisher